| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 111,065 | |||
| Marketable securities | 350,797 | |||
| Accounts receivable, net | 21,430 | |||
| Accounts receivable - related parties | 929 | |||
| Prepaid expenses and other current assets | 21,861 | |||
| Total current assets | 506,082 | |||
| Property, plant and equipment, net | 176,579 | |||
| Operating lease right-of-use assets | 368,213 | |||
| Investments | 30,175 | |||
| Intangible assets, net | 61,522 | |||
| Other non-current assets | 46,594 | |||
| Total assets | 1,189,165 | |||
| Accounts payable | 10,704 | |||
| Deferred revenue (includes 311 and 795 from related parties) | 25,236 | |||
| Accrued expenses and other current liabilities | 79,341 | |||
| Total current liabilities | 115,281 | |||
| Deferred revenue, net of current portion (includes 64,786 and 72,260 from related parties) | 74,072 | |||
| Operating lease liabilities, non-current | 422,870 | |||
| Other non-current liabilities | 17,159 | |||
| Total liabilities | 629,382 | |||
| Common stock, 0.0001 par value (note 8) | 6 | |||
| Additional paid-in capital | 6,627,350 | |||
| Accumulated deficit | -6,069,569 | |||
| Accumulated other comprehensive income (loss) | 1,996 | |||
| Total stockholders equity | 559,783 | |||
| Total liabilities and stockholders equity | 1,189,165 | |||
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)